Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Altria Group
MO
|
+$1.83B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.48B |
| 3 |
Lyft
LYFT
|
+$1.45B |
| 4 |
GE Aerospace
GE
|
+$1.37B |
| 5 |
NXP Semiconductors
NXPI
|
+$1.07B |
Top Sells
| 1 |
Apple
AAPL
|
+$2.16B |
| 2 |
Amazon
AMZN
|
+$2.06B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.6B |
| 4 |
Amgen
AMGN
|
+$1.48B |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.27B |
Sector Composition
| 1 | Technology | 19.83% |
| 2 | Healthcare | 16.01% |
| 3 | Financials | 14.99% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
8x8 Inc
EGHT
$286M
| $9.11M | ﹤0.01% |
450,856
-291,628
| -39% | -$5.89M |
|
|
REGI
1827
DELISTED
Renewable Energy Group, Inc.
REGI
| $9.1M | ﹤0.01% |
414,571
-190,700
| -32% | -$4.19M |
|
1828
Arvinas
ARVN
$568M
| $9.02M | ﹤0.01% |
611,000
| – | – |
|
1829
Corcept Therapeutics
CORT
$7.68B
| $8.98M | ﹤0.01% |
764,795
+203,200
| +36% | +$2.39M |
|
1830
EQT Corp
EQT
$31.8B
| $8.97M | ﹤0.01% |
432,707
-1,348,712
| -76% | -$28M |
|
1831
Karyopharm Therapeutics
KPTI
$55.9M
| $8.96M | ﹤0.01% |
102,253
-22,756
| -18% | -$1.99M |
|
|
TBCH
1832
Turtle Beach Corporation Common Stock
TBCH
$299M
| $8.94M | ﹤0.01% |
786,616
+125,784
| +19% | +$1.43M |
|
1833
OneSpan
OSPN
$588M
| $8.91M | ﹤0.01% |
463,648
-7,988
| -2% | -$154K |
|
1834
Smart Sand
SND
$75.1M
| $8.88M | ﹤0.01% |
1,996,206
-632,650
| -24% | -$2.82M |
|
|
TBI
1835
Trueblue
TBI
$179M
| $8.84M | ﹤0.01% |
374,035
-28,724
| -7% | -$679K |
|
|
ABMD
1836
DELISTED
Abiomed Inc
ABMD
| $8.83M | ﹤0.01% |
30,927
+22,940
| +287% | +$6.55M |
|
|
DBVT
1837
DBV Technologies
DBVT
$270M
| $8.8M | ﹤0.01% |
114,109
-742
| -0.6% | -$57.2K |
|
1838
Texas Pacific Land
TPL
$21.5B
| $8.79M | ﹤0.01% |
34,065
+25,365
| +292% | +$6.54M |
|
1839
Assembly Biosciences
ASMB
$168M
| $8.78M | ﹤0.01% |
37,143
+223
| +0.6% | +$52.7K |
|
|
PRSP
1840
DELISTED
Perspecta Inc. Common Stock
PRSP
| $8.77M | ﹤0.01% |
433,945
+79,853
| +23% | +$1.61M |
|
|
VSTO
1841
DELISTED
Vista Outdoor Inc.
VSTO
| $8.73M | ﹤0.01% |
1,090,354
-164,143
| -13% | -$1.31M |
|
|
FRBK
1842
DELISTED
Republic First Bancorp Inc
FRBK
| $8.71M | ﹤0.01% |
1,659,777
-77,123
| -4% | -$405K |
|
|
CBB
1843
DELISTED
Cincinnati Bell Inc.
CBB
| $8.68M | ﹤0.01% |
910,172
+13,200
| +1% | +$126K |
|
1844
Belden
BDC
$5.21B
| $8.67M | ﹤0.01% |
161,500
-5,523
| -3% | -$297K |
|
1845
CRISPR Therapeutics
CRSP
$5.12B
| $8.66M | ﹤0.01% |
242,336
-73,500
| -23% | -$2.63M |
|
1846
Rapid7
RPD
$1.27B
| $8.62M | ﹤0.01% |
170,286
+112,677
| +196% | +$5.7M |
|
|
ARE.PRD
1847
DELISTED
Alexandria Real Estate Equities, Inc. 7.00% Series D Cumulative Convertible Preferred Stock
ARE.PRD
| $8.61M | ﹤0.01% |
227,150
| – | – |
|
1848
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $8.59M | ﹤0.01% |
168,162
+120,074
| +250% | +$6.13M |
|
|
QTS.PRB
1849
DELISTED
QTS Realty Trust, Inc. 6.50% Series B Cumulative Convertible Perpetual Preferred Stock
QTS.PRB
| $8.38M | ﹤0.01% |
77,000
+27,000
| +54% | +$2.94M |
|
1850
Corbus Pharmaceuticals
CRBP
$116M
| $8.37M | ﹤0.01% |
40,152
-7,000
| -15% | -$1.46M |
|